Analgesics (Pharmacies) - Papua New Guinea

Revenue in the Analgesics market is projected to reach US$10.59m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.88%, resulting in a market volume of US$14.76m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$1.01 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Papua New Guinea is experiencing significant development and growth.

Customer preferences: Customers in Papua New Guinea have shown a strong preference for analgesics purchased from pharmacies. They trust the expertise and knowledge of pharmacists in recommending the right pain relief medication for their needs. This preference for purchasing analgesics from pharmacies is driven by the perception that these products are of higher quality and more reliable than those available from other sources.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in Papua New Guinea is the increasing demand for over-the-counter (OTC) analgesics. Customers are becoming more proactive in managing their own health and are seeking accessible and affordable pain relief solutions. This trend is driven by the growing awareness of the benefits of self-care and the convenience of purchasing OTC analgesics from pharmacies without the need for a prescription. As a result, pharmacies are expanding their range of OTC analgesics to cater to this increasing demand. Another trend in the market is the rising popularity of natural and herbal analgesics. Customers in Papua New Guinea are increasingly seeking alternatives to traditional pharmaceutical analgesics, favoring natural and herbal remedies. This trend is driven by the growing interest in holistic health and the belief that natural remedies are safer and have fewer side effects. Pharmacies are responding to this trend by stocking a wider range of natural and herbal analgesics to meet the evolving needs and preferences of their customers.

Local special circumstances: Papua New Guinea has a unique healthcare system and infrastructure challenges that impact the Analgesics (Pharmacies) market. The country has a relatively low doctor-to-patient ratio, which means that many people rely on pharmacies as their primary source of healthcare advice and medication. This reliance on pharmacies creates a significant opportunity for the growth of the Analgesics (Pharmacies) market as customers seek accessible and reliable pain relief solutions.

Underlying macroeconomic factors: The development of the Analgesics (Pharmacies) market in Papua New Guinea is also influenced by underlying macroeconomic factors. The country has been experiencing steady economic growth, which has resulted in an increase in disposable income and improved access to healthcare services. This economic growth has contributed to the rising demand for analgesics as customers have more purchasing power to invest in their health and well-being. In conclusion, the Analgesics (Pharmacies) market in Papua New Guinea is developing due to customer preferences for purchasing analgesics from pharmacies, the increasing demand for OTC analgesics, the popularity of natural and herbal remedies, the unique healthcare system and infrastructure challenges in the country, and the underlying macroeconomic factors such as economic growth and increased disposable income.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.